TITLE

Moment of truth

AUTHOR(S)
Aiken, John
PUB. DATE
October 2007
SOURCE
Pharmaceutical Representative;Oct2007, Vol. 37 Issue 10, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers a step-by-step guidelines to help sales representatives spend more time with their physicians to share information or provide tangible value to the physician's day.
ACCESSION #
26947404

 

Related Articles

  • Doctors prefer specialty reps.  // Medical Marketing & Media;Mar2001, Vol. 36 Issue 3, p7 

    Focuses on the preference of physicians to be visited by a specialty sales representative. Influence of specialty representative on the prescribing decisions of physicians; Knowledge of specialty representative about specific therapeutic areas.

  • Should you see a drug rep calling on spec? Moore, Peter // Pulse;11/3/2003, Vol. 63 Issue 44, p72 

    Advises physicians on how to deal with visits by pharmaceutical sales representatives. Proper approach to the pharmaceutical industry; Appropriateness of seeing a sales agent without an appointment; Belief on the evidence presented by sales agents; Guidelines followed by drug companies.

  • Study shows sales reps feel the crunch. Arnold, Matthew // Medical Marketing & Media;Nov2003, Vol. 38 Issue 11, p12 

    Focuses on the reduced access of pharmaceutical sales representatives to physicians in the U.S. Challenges of product promotion.

  • What Doctors Want. Prounis, Charlene // Pharmaceutical Executive;May2003 Supplement, Vol. 23 Issue 5, p12 

    Reports on the relationship between physicians and pharmaceutical sales representative in the U.S. Establishment of trust by presenting balanced information about the product; Collegial level of interaction; Compliance to the marketing code of Pharmaceutical Research and Manufacturers of...

  • Details, details: What your colleagues think of drug reps. Murray, Dennis // Medical Economics;6/7/2002, Vol. 79 Issue 11, p41 

    Focuses on the physicians' perception on pharmaceutical sales representatives. Reasons for the physicians' refusal to see sales representatives; Information on the unethical behavior of sales representatives.

  • Market Pulse. Breitstein, Joanna // Pharmaceutical Executive;May2003, Vol. 23 Issue 5, p116 

    Reports on the view of physicians regarding the marketing code of the Pharmaceutical Research and Manufacturers of America in the U.S. Limit of the education delivered by pharmaceutical companies; Change in the relation with sales representatives; Level of attendance at pharma-sponsored meetings.

  • To Sell a Doctor Think Like a Doctor. Kessler, Michael // Pharmaceutical Executive;May2003, Vol. 23 Issue 5, p146 

    Reports on the strategies to enhance sales volume of pharmaceuticals and promote health products to physicians in the U.S. Mental and physical access of sales representatives to physician customers; Value of clinical study to establish the credibility of sales personnel; Liability of physicians...

  • The trust factor. Sandroff, Ronni // Consumer Reports on Health;Aug2004, Vol. 16 Issue 8, p2 

    Discusses health issues in the U.S. Amount spent by drug manufacturers on sampling and detailing to doctors in 2001; View of newsletter readers in Phoenix on visits by drug salespeople; Factors that can improve the trust in the patient-doctor relationship.

  • Breaking it Down. Acton, Kevin // Pharmaceutical Representative;Sep2010, Vol. 40 Issue 9, p30 

    The article offers the author's insights of the significance of the tool "Call Profile Worksheet (CPW)" which he has developed to evaluate the physician-representative interaction for pharmaceutical sales representative in pharmaceutical industry in the U.S. He tackles the CPW structure...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics